Cohance Lifesciences Limited Isosorbide Export Data — India (DGFT 2022–2026)

Name: Cohance Lifesciences Limited Isosorbide Export Records India — #2 Exporter, 141 Shipments, $7.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Isosorbide

India Pharmaceutical Trade Intelligence

$44.9M181 Suppliers102 CountriesHS 30049099

ExportsIndia → UNITED STATES85.6%India → UNITED KINGDOM3.1%

ImportsUNITED STATES → India$345.3K GERMANY → India$186.9K

#1 Buyer: TORRENT PHARMA

Cohance Lifesciences Limited — Isosorbide Exporter #2 | $7.0M Trade Value | TransData Nexus | TransData Nexus

Cohance Lifesciences Limited — Isosorbide Exporter Profile

Indian Pharmaceutical Exporter · #2 for Isosorbide · $7.0M export value · DGFT Verified

Cohance Lifesciences Limited is the #2 Indian exporter of Isosorbide with $7.0M in export value and 141 verified shipments. Cohance Lifesciences Limited holds a 15.7% market share in Isosorbide exports across 1 countries. The company exports 4 pharmaceutical products worth $13.6M across 4 therapeutic categories.

Cohance Lifesciences Limited — Isosorbide Export Profile: Buyers & Destinations

Cohance Lifesciences Limited Isosorbide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Isosorbide?

Country	Value	Shipments	Share
UNITED STATES	$35.6M	712	85.2%
UNITED KINGDOM	$1.4M	81	3.4%
BRAZIL	$1.2M	40	2.8%
PHILIPPINES	$1.1M	52

Who Are the Top Buyers of Isosorbide from India?

Buyer	Country	Value	Orders
INGENUS PHARMACEUTICALS, LLC	UNITED STATES	$4.8M	96
TORRENT PHARMA INC	UNITED STATES	$4.5M	90
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$3.4M	105
INGENUS PHARMACEUTICALS LLC	UNITED STATES	$2.2M	44
WOODFIELD DISTRIBUTION LLC.	UNITED STATES	$1.2M	33
TORRENT PHARMA INC,	UNITED STATES	$1.1M	64
ZYDUS NIKKHO FARMACEUTICA LTDA	BRAZIL	$997.3K	35
INGENUS PHARMACEUTICALS,LLC	UNITED STATES	$850.0K	17
TORRENT PHARMA INC C/O,	UNITED STATES	$788.3K	26
WOODFIELD DISTRIBUTION LLC	UNITED STATES	$720.8K	16

India's Isosorbide is purchased by 537 buyers worldwide. The top buyer is INGENUS PHARMACEUTICALS, LLC (UNITED STATES), followed by TORRENT PHARMA INC and EVERSANA LIFE SCIENCES SERVICES LLC.

How Does Cohance Lifesciences Limited Compare to Nearest Isosorbide Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	TORRENT PHARMACEUTICALS LTD	$8.3M	165	5	$50.0K
2	COHANCE LIFESCIENCES LIMITED ★	$7.0M	141	1	$50.0K
3	RUBICON RESEARCH PRIVATE LIMITED	$4.9M	146	1	$33.5K
5	ZYDUS LIFESCIENCES LIMITED	$2.4M	161	6	$14.6K

Cohance Lifesciences Limited ranks #2 among 181 Indian Isosorbide exporters. Average shipment value of $50.0K compared to the market average of $164.5K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and RUBICON RESEARCH PRIVATE LIMITED.

Which Indian Ports Ship Isosorbide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	412	21.0%
SAHAR AIR	308	15.7%
NHAVA SHEVA SEA (INNSA1)	168	8.6%
Bombay Air	92	4.7%
JNPT/ NHAVA SHEVA SEA	86	4.4%
DELHI AIR	74	3.8%
HYDERABAD ICD	64	3.3%
DELHI AIR CARGO ACC (INDEL4)	52	2.7%

Geopolitical & Trade Policy Impact on Cohance Lifesciences Limited's Isosorbide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cohance Lifesciences. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and shipping costs. This situation necessitates strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost efficiency.

Conversely, the U.S.-China trade tensions have opened avenues for Indian exporters to capture market share previously dominated by Chinese manufacturers. Cohance's established presence and compliance with international standards position it favorably to meet the increased demand from U.S. importers seeking reliable alternatives.

The recent India-European Union Free Trade Agreement (FTA), concluded on January 27, 2026, eliminates tariffs on Indian pharmaceutical exports to the EU, including duties of up to 11% on pharmaceuticals. This development enhances Cohance's competitiveness in the European market, potentially boosting export volumes and revenues. (en.wikipedia.org)

Cohance Lifesciences Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. The USFDA's issuance of a warning letter to Cohance's Hyderabad facility highlights the critical importance of adhering to Good Manufacturing Practices (GMP). While the immediate financial impact may be minimal due to the facility's limited contribution to U.S. revenues, the long-term implications on reputation and market access are significant. Proactive remediation and transparent communication with regulatory bodies are essential to restore and maintain compliance.

Additionally, the European Union's Falsified Medicines Directive (FMD) imposes stringent requirements on pharmaceutical imports. Cohance must ensure robust serialization and traceability measures to comply with these regulations, thereby safeguarding its access to the lucrative EU market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Isosorbide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cohance Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 102+ countries, 537+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Isosorbide

Isosorbide

Cohance Lifesciences Limited — Isosorbide Exporter Profile

Cohance Lifesciences Limited — Isosorbide Export Profile: Buyers & Destinations

Where Does India Export Isosorbide?

Who Are the Top Buyers of Isosorbide from India?

What Is India's Total Isosorbide Export Value and How Much Does Cohance Lifesciences Limited Contribute?

What Is the Average Shipment Value for Cohance Lifesciences Limited's Isosorbide Exports?

How Does Cohance Lifesciences Limited Compare to Other Indian Isosorbide Exporters?

Regulatory Requirements: Exporting Isosorbide to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Cohance Lifesciences Limited Compare to Nearest Isosorbide Exporters?

Which Indian Ports Ship Isosorbide Exports?

Geopolitical & Trade Policy Impact on Cohance Lifesciences Limited's Isosorbide Exports

Cohance Lifesciences Limited — Regulatory Compliance & Quality Standards

About Cohance Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Isosorbide Export Data from Cohance Lifesciences Limited

Isosorbide Stats

Company Overview

Top Products by Cohance Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source